The evolving treatment landscape in Still's disease The Lancet Rheumatology + + +...

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(25)00192-4/fulltext?dgcid=raven_jbs_etoc_email Aug 2025 Volume 7Number 8e521-e590 https://www.thelancet.com/journals/lanrhe/issue/vol7no8/PIIS2665-9913(25)X0008-4 Sarilumab in relapsing polymyalgia rheumatica: patient-reported outcomes from a phase 3, double-blind, randomised controlled trial https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(25)00041-4/abstract?dgcid=raven_jbs_etoc_feature_lanrhe